Literature DB >> 8626784

hCDC47, a human member of the MCM family. Dissociation of the nucleus-bound form during S phase.

M Fujita1, T Kiyono, Y Hayashi, M Ishibashi.   

Abstract

hCDC47 is a putative human homologue of yeast CDC47 and a member of the MCM protein family, which has been implicated in the regulatory machinery causing DNA to replicate only once in the S phase. In the present study, we performed an initial characterization of hCDC47. We found that hCDC47 protein was present in the nucleus of cultured human cells in two different forms; one extractable by a non-ionic detergent and the other resistant to such extraction and tightly associated with the nucleus. The levels of the nucleus-bound form gradually diminished during S phase progression, although the total amount of nuclear hCDC47 protein remained relatively constant, suggesting that the nucleus-bound form becomes dissociated from the nuclear structure during DNA replication. This behavior of hCDC47 protein is very similar to that of other mammalian MCM proteins reported recently. We also found that expression of hCDC47 mRNA was repressed in quiescent cells but was induced at the late G1 to S phase by growth factor stimulation. Together, these findings indicate that hCDC47 protein together with other MCM proteins participates in the regulation of mammalian DNA replication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626784     DOI: 10.1074/jbc.271.8.4349

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Retinoblastoma tumor suppressor protein signals through inhibition of cyclin-dependent kinase 2 activity to disrupt PCNA function in S phase.

Authors:  Z Sever-Chroneos; S P Angus; A F Fribourg; H Wan; I Todorov; K E Knudsen; E S Knudsen
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 2.  Eukaryotic MCM proteins: beyond replication initiation.

Authors:  Susan L Forsburg
Journal:  Microbiol Mol Biol Rev       Date:  2004-03       Impact factor: 11.056

3.  The basic helix-loop-helix transcription factor Nex-1/Math-2 promotes neuronal survival of PC12 cells by modulating the dynamic expression of anti-apoptotic and cell cycle regulators.

Authors:  Martine Uittenbogaard; Anne Chiaramello
Journal:  J Neurochem       Date:  2005-02       Impact factor: 5.372

4.  Progesterone blocks estrogen-induced DNA synthesis through the inhibition of replication licensing.

Authors:  Haiyan Pan; Yan Deng; Jeffrey W Pollard
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-11       Impact factor: 11.205

5.  hDREF regulates cell proliferation and expression of ribosomal protein genes.

Authors:  Daisuke Yamashita; Yukako Sano; Yuka Adachi; Yuma Okamoto; Hirotaka Osada; Takashi Takahashi; Tomohiro Yamaguchi; Takashi Osumi; Fumiko Hirose
Journal:  Mol Cell Biol       Date:  2007-01-12       Impact factor: 4.272

6.  Negative regulation of DNA replication by the retinoblastoma protein is mediated by its association with MCM7.

Authors:  J M Sterner; S Dew-Knight; C Musahl; S Kornbluth; J M Horowitz
Journal:  Mol Cell Biol       Date:  1998-05       Impact factor: 4.272

7.  The RLF-M component of the replication licensing system forms complexes containing all six MCM/P1 polypeptides.

Authors:  P Thömmes; Y Kubota; H Takisawa; J J Blow
Journal:  EMBO J       Date:  1997-06-02       Impact factor: 11.598

8.  Stem cell factor stimulates neurogenesis in vitro and in vivo.

Authors:  Kunlin Jin; Xiao Ou Mao; Yunjuan Sun; Lin Xie; David A Greenberg
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  Origin licensing and p53 status regulate Cdk2 activity during G(1).

Authors:  Kathleen R Nevis; Marila Cordeiro-Stone; Jeanette Gowen Cook
Journal:  Cell Cycle       Date:  2009-06-21       Impact factor: 4.534

10.  MCM7 expression is altered in rat after spinal cord injury.

Authors:  Jiajia Chen; Zhiming Cui; Weidong Li; Aiguo Shen; Guanhua Xu; Guofeng Bao; Yuyu Sun; Lingling Wang; Jianbo Fan; Jinlong Zhang; Longfei Yang; Zhiming Cui
Journal:  J Mol Neurosci       Date:  2013-03-26       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.